Chinese biopharma firm Adlai Nortye bags $100m in a Series D round

Chinese biopharma firm Adlai Nortye bags $100m in a Series D round

Photo: Pixabay

Liya Su

13 July, 2021

Hangzhou Adlai Nortye Biopharma

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.